Melasma is a skin condition characterized by dark patches that most commonly appear on the face. While more research is needed to pinpoint its exact cause, several well-known triggers are recognized. Although melasma is generally asymptomatic, the visible contrast of hyperpigmentation against unaffected skin, especially on the face, often makes it a concerning issue that many seek treatment for.
Melasma is more prevalent in women, typically between the ages of 20-40, and is more common in individuals with darker skin tones. There may be a genetic component to melasma, although the specific gene remains unknown.
Frequent triggers include:
Melasma can persist for years or resolve more quickly once the triggering factor is removed.
Topical treatments include regimens with hydroquinone (a traditional “bleaching” cream, although not for long-term use as it may cause darkening with prolonged application), dicarboxylic acids like azelaic acid and kojic acid, mild corticosteroids, and tretinoin.
Procedural options include microneedling, chemical peels, and laser treatments; however, caution is needed with the latter two, as stronger treatments can lead to post-inflammatory hyperpigmentation if they “burn” or damage the skin.
A key strategy for managing melasma is trigger avoidance. This involves minimizing sun exposure, using mineral-based sunscreen (which blocks both UV and visible light), and coordinating care for any relevant medications or thyroid concerns with a healthcare provider.